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INTRODUCTION 
 
Around the time of parturition, it is common for dairy cows to experience decreased 
blood Ca due to a decrease in dry matter intake (DMI) and an increase in Ca demand for 
colostrogenesis and subsequent milk production. Hypocalcemia ensues when blood Ca 
drops below normal ranges, and is associated with an increased risk of developing other 
health disorders (Kimura et al., 2006; Chapinal et al., 2011; Martinez et al., 2012), 
decreased milk production (Chapinal et al., 2012), and reduced reproductive performance 
(Chapinal et al., 2012; Martinez et al., 2012; Caixeta et al., 2017). 
 
One strategy for preventing hypocalcemia is to feed a Ca-deficient (< 20 g/d 
available Ca) prepartum diet, which will cause a slight decrease in blood Ca and stimulate 
parathyroid hormone (PTH) secretion (Goings et al., 1974; Kichura et al., 1982). 
Parathyroid hormone mobilizes skeletal Ca when blood Ca concentrations drop and 
increases Ca absorption efficiency in the small intestine and Ca reabsorption in the kidney 
(Goff, 2006). Due to Ca concentrations found in common feedstuffs, it is difficult to 
formulate a prepartum diet sufficiently low in Ca to result in homeostatic changes (Horst 
et al., 2005). However, the effects of a low Ca dietary approach can be actualized by 
decreasing the bioavailability of dietary Ca through the use of a Ca binding agent. In an 
in vitro study, Thilsing et al. (2006) showed that synthetic zeolite A, a sodium aluminum 
silicate, has the capacity to bind to Ca, P and Mg in rumen fluid at varying pH levels. 
However, the binding capacity of zeolite A to microminerals that may play an important 
role in combating oxidative stress has not been investigated. Previous studies have 
shown that feeding zeolite A during the prepartum period results in improved Ca status 
during the periparturient period and is hypothesized to be a result of actualizing a low Ca 
prepartum diet (Thilsing-Hansen et al., 2002; Thilsing et al., 2007; Pallesen et al., 2008). 
Only one study has observed the effects of feeding zeolite A for more than 2 weeks. 
Despite observing improved Ca status on the day after calving in this study, cow numbers 
were limited as only 9 Jersey cows were fed zeolite A (Thilsing-Hansen and Jørgensen, 
2001). Subsequent studies limited zeolite A supplementation to the 2 weeks prior to 
expected calving (Thilsing et al., 2007; Pallesen et al., 2008; Grabherr et al., 2009). It is 
common for North American commercial dairy farms to utilize a 2-group dry cow strategy 
such that animals move to a close-up pen 21 to 28 d prior to expected calving. Despite 
demonstrating improved blood Ca status, further research is needed to investigate the 
effects of feeding zeolite A on intake and performance as well as the potential effects on 
immune function and reproductive performance that may result from altering blood 
mineral status.   
 
The objective of this study was to determine the effects of feeding zeolite A for 3 
weeks prior to expected calving to multiparous Holstein cows on serum mineral status, 
plasma oxidant status, DMI, milk production, and reproductive performance. We 
hypothesized that zeolite-fed cows would have improved Ca status during the postpartum 
period, resulting in improved postpartum outcomes.  
 
EXPERIMENTAL DESIGN 
 
 All procedures involving animals were approved by the Cornell University 
Institutional Animal Care and Use Committee prior to the onset of the experiment. Cows 
(n = 55) were enrolled in a completely randomized design study, with randomization 
restricted to balance for parity group (entering 2nd vs. 3rd and greater lactation) and 
previous 305-d mature equivalent milk production. Cows were fed a control diet beginning 
at 28 d prior to expected parturition for a covariate (pretreatment) period of 7 d. Animals 
were housed in individual tie-stalls with individual feed bins. At 21 d prior to expected 
parturition, cows were assigned to 1 of 2 treatment groups, Control (CON) or 
Experimental (EXP). Diets were identical except for the addition of synthetic zeolite A (X-
Zelit, Protekta Inc., Lucknow, Ontario, Canada/Vilofoss, Graasten, Denmark) in the EXP 
diet. After parturition, all cows were fed the same fresh cow diet and managed similarly 
until 28 DIM.   
 
 Diets were formulated using the Cornell Net Carbohydrate and Protein System 
(CNCPS, version 6.55, Cornell University, Ithaca, NY). Ration ingredient composition and 
analyzed diet composition are presented in Table 1. In the EXP diet, zeolite A was fed at 
3.3% of DM, targeting 500 g/d as fed. Cows were individually fed and the weight of feed 
delivered and refused was recorded to calculate daily feed intake. Weekly TMR samples 
and feed ingredient samples were collected for determination of DM and the as-fed 
inclusion rate of the ration ingredients were adjusted weekly based on the DM values. 
Forages and TMR samples were dried and ground; TMR samples were composited at 4-
wk intervals and feed ingredients were composited over the course of the study. 
Composited samples were submitted to a commercial laboratory (Cumberland Valley 
Analytical Services, Waynesboro, PA) for wet chemistry analysis.  
 
Body weight was measured and a BCS was assigned weekly for each cow from 
enrollment through 28 DIM. Rumination data were collected with HR tags (SCR Dairy, 
Netanya, Israel) in 2-h intervals from enrollment through 28 DIM. Colostrum was 
harvested within 2 h of calving, weighed, and sampled for determination of IgG 
concentration (Cornell University Animal Health Diagnostic Center, Ithaca, NY). All cows 
were milked 3×/d and daily milk weights were recorded. Milk samples were taken weekly 
at 3 consecutive milkings for wk 1 through 4 of lactation and analyzed for milk composition 
in the Barbano lab at Cornell University using Fourier transform mid-infrared (FTIR) 
techniques (Barbano et al., 2014).  
 
Table 1. Formulated and analyzed (mean ± SD) diet composition of the prepartum diets 
and the common postpartum diet. 
 Prepartum   
Item CON EXP  Postpartum 
Ingredient, % of diet DM     
Corn silage 40.00 38.60  40.25 
Alfalfa hay ― ―  3.58 
Wheat straw  33.33 32.17  4.48 
Alfalfa silage ― ―  10.74 
Canola meal 8.33 8.03  5.37 
Ground shelled corn ― ―  3.58 
Steam flaked corn ― ―  6.27 
Citrus pulp 3.33 3.24  2.02 
Blood meal 1.67 1.62  ― 
Amino Plus1 6.67 6.47  6.14 
Smartamine M2 0.03 0.05  ― 
LysAAmet3 ― ―  1.77 
Soybean hulls 5.00 4.85  3.74 
Dried molasses ― ―  4.08 
X-Zelit4 ― 3.40  ― 
Urea ― ―  0.41 
Other 1.6 1.56  7.53 
Analyses, % of diet DM     
CP 13.6 ± 1.0 13.5 ± 0.7  16.4 ± 0.4 
NDF 46.4 ± 1.4 46.0 ± 1.7  30.6 ± 2.8 
Starch 16.8 ± 1.7 16.3 ± 0.3  26.1 ± 1.6 
Sugar 3.2 ± 0.8 3.3 ± 0.4  3.3 ± 0.5 
Fat 2.24 ± 0.13 2.25 ± 0.30  2.64 ± 0.24 
Ash 6.12 ± 0.53 7.99 ± 0.36  9.14 ± 0.49 
Ca 0.68 ± 0.05 0.65 ± 0.03  1.00 ± 0.07 
P 0.39 ± 0.03 0.38 ± 0.02  0.38 ± 0.01 
Mg 0.42 ± 0.05 0.42 ± 0.03  0.51 ± 0.04 
DCAD, mEq/100 g of DM 11.03 ± 2.06 26.87 ± 1.71  40.75 ± 2.54 
MP, g/kg of DM5 87.24 85.41  123.04 
1 Ag Processing Inc., Omaha, NE. 
2 Adisseo, Antony, France. 
3 Perdue AgSolutions LLC, Salisbury, MD. 
4 Protekta, Inc., ON, Canada/Vilofoss, Graasten, Denmark. 
5 Metabolizable protein as predicted by the Cornell Net Carbohydrate and Protein System, based 
on analyzed forage composition. 
 
Blood samples were collected 1×/wk from enrollment until 7 d prior to expected 
calving, then daily through 7 DIM, with 2 samples collected within 24 h of parturition, and 
3×/wk from 8 to 28 DIM. A subset of serum samples were analyzed for Ca, P, and Mg 
concentrations at the Cornell University Animal Health Diagnostic Center (Ithaca, NY). 
Samples were classified as normal Ca (Ca ≥ 2.12 mmol/L) or low Ca (Ca < 2.12 mmol/L) 
to determine subclinical hypocalcemia (SCH) prevalence (Goff, 2008). The 4 serum 
samples analyzed between calving and 3 DIM were evaluated to determine overall Ca 
status of the cow. Similar to Caixeta et al. (2017), cows were also retrospectively 
classified as having eucalcemia (no SCH; 0 samples with Ca < 2.12 mmol/L), SCH (1 to 
3 samples with Ca < 2.12 mmol/L), or chronic SCH (cSCH; all 4 samples with Ca < 2.12 
mmol/L) between calving and 3 DIM.  
 
A subset of plasma samples were analyzed for oxidant status according to Abuelo 
et al. (2016). In order to assess oxidative stress during the transition period, the oxidant 
status index [OSi; OSi = (reactive nitrogen and oxygen species; RONS) / (antioxidant 
potential; AOP)] was evaluated as it reflects the changes in redox balance (Abuelo et al., 
2013, 2016). 
 
Prepartum and postpartum data were analyzed separately. All statistical analyses 
were conducted with SAS (version 9.4, SAS Institute Inc., Cary, NC). The prevalence of 
hypocalcemia between treatments by day was tested with a Fisher’s exact test using 
PROC FREQ. Continuous measures not repeated over time were subjected to ANOVA 
using the MIXED procedure with fixed effects of treatment, parity group and the 
interaction between treatment and parity group. Data analyzed over time were subjected 
to repeated measures ANOVA using the MIXED procedure and the repeated statement 
for time. Fixed effects included in the model were treatment, time, parity group, and all 
two-way interactions with the random effect of cow within treatment. Pretreatment 
measures were included in the model when available as covariates. The effect of 
treatment and Ca status, both with the fixed effect of parity, on time to pregnancy by 150 
DIM were analyzed by a Cox Proportional Hazards model using the PHREG procedure. 
Cows that were removed from the herd before becoming pregnant or were not pregnant 
by 150 DIM were right censored. 
 
RESULTS 
 
 Prepartum and postpartum serum mineral concentrations and plasma OSi are 
presented in Table 2 and treatment by day effects are presented in Figure 1 for serum 
Ca, P, and Mg. Cows fed EXP during the prepartum period had higher serum Ca 
concentrations, most notably as parturition approached and in the immediate postpartum 
period. Serum P concentrations in the EXP-fed cows were approximately half the 
concentration of the CON-fed cows during the entire prepartum period.  Serum P levels 
in EXP-fed cows were significantly lower than CON-fed cows during the immediate 
postpartum period yet increased through 14 DIM such that EXP-fed cows had significantly 
higher P concentrations at d 14. Magnesium concentrations steadily decreased during 
the prepartum period for EXP-fed cows and on average, were lower than the CON-fed 
cows. Serum Mg was markedly lower for EXP-fed cows within the first DIM but we did not 
observe treatment by day interactions thereafter. There were no significant treatment 
differences in the OSi during the prepartum or postpartum periods.   
  
Table 2. Least squares means and SEM for prepartum and postpartum serum mineral 
concentrations and geometric means with back transformed 95% confidence 
intervals for oxidant status index (OSi). 
 Treatment  P-value 
Variable CON EXP SEM Trt Trt × Day 
Prepartum      
Ca (mmol/L) 2.31 2.47 0.02 <0.001 0.06 
P (mmol/L) 2.03 1.03 0.04 <0.001 0.04 
Mg (mmol/L) 0.92 0.85 0.01 <0.01 <0.01 
OSi4 1.33 (1.24–1.44) 1.34 (1.24–1.45) ― 0.93 0.60 
Postpartum      
Ca (mmol/L) 2.15 2.33 0.02 <0.001 <0.001 
P (mmol/L) 1.39 1.19 0.04 <0.001 <0.001 
Mg (mmol/L) 0.92 0.91 0.01 0.51 <0.001 
OSi 0.97 (0.90–1.05) 0.99 (0.91–1.07) ― 0.77 0.33 
 
 
Figure 1. Serum concentrations of Ca (A), P (B), Mg (C),  by day relative to calving with 
significant differences indicated by an asterisk (*; P ≤ 0.05). 
 
Subclinical hypocalcemia (SCH) prevalence for the two treatment groups at 
different time points are presented in Figure 2A. There were 3× as many CON-fed cows 
that had serum Ca concentration < 2.12 mmol/L within the first DIM compared to the EXP-
fed cows. The highest prevalence of SCH occurred within d 1 postpartum for both 
treatment groups. The CON-fed cows had a greater prevalence of SCH from 3 days prior 
to calving through 3 DIM. Fourteen out of 55 cows were categorized as not having SCH 
from calving through 3 DIM; only one of these cows were in the CON-fed group. Fifty 
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percent (n = 13) of EXP-fed cows and 62.1% (n = 18) of CON-fed cows were categorized 
as having SCH. We did not observe any EXP-fed cows with cSCH while 34.5% (n = 10) 
of CON-fed cows were categorized as having cSCH (Figure 2B).  
 
 
Figure 2. A) Prevalence of subclinical hypocalcemia (Ca < 2.12 mmol/L) by day relative 
to calving. Days at which treatments significantly differed are indicated with 
asterisks (*; P ≤ 0.05). B) The proportion of cows classified based on the severity 
of hypocalcemia from calving through 3 DIM. Cows were eucalcemic (no SCH) 
if 0 samples were < 2.12 mmol/L, subclinically hypocalcemic (SCH) if 1 to 3 
samples were < 2.12 mmol/L, and chronically subclinically hypocalcemic 
(cSCH) if all 4 samples were < 2.12 mmol/L. 
 
Prepartum and postpartum DMI, EBAL, rumination, BW, change in BW, and BCS 
are presented in Table 3. We observed a treatment by week effect such that EXP-fed 
cows had similar DMI at 3 weeks prior to calving but had a greater reduction in DMI 
compared to CON-fed cows as parturition approached. There were no effects of treatment 
or interactions between treatment and week on postpartum DMI. While not significantly 
different at individual weeks, numerically DMI was 1 kg/d lower in the week before 
parturition and 1 kg/d higher in the first week postpartum for cows fed EXP compared to 
CON-fed cows. Cows fed the EXP diet ruminated for less time per day compared to CON-
fed cows during the prepartum period with no effects of treatment during the postpartum 
period. Cows fed EXP gained less weight as calving approached compared to CON-fed 
cows. Prepartum BCS was lower in EXP-fed cows however, the absolute differences are 
small. We observed a treatment by week effect for BCS such that EXP-fed cows had a 
numerically lower BCS during wk 1 and 3 and was not different at wk 2 and 4.  
 
Colostrum measurements, milk yield, and milk composition results are presented 
in Table 3. Despite improved Ca status during the periparturient period in cows fed the 
EXP diet, these cows did not have improved IgG concentration or IgG yield compared to 
cows fed the CON diet. We found no differences in milk yield between treatments nor did 
we observe a difference in ECM. Fat and protein yield also did not differ between 
treatments however, we observed a tendency for EXP-fed cows to have a higher protein 
and total solids concentration over wk 1 through 4.  
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Table 3. Least squares means and SEM for prepartum and postpartum DMI, energy 
balance (EBAL), rumination, BW, BCS, colostrum measurements, and milk 
composition over the first 4 wk of lactation.  
 Treatment  P-value 
Variable CON EXP SEM Trt Trt × Time 
Prepartum          
 DMI (kg/d) 14.6 14.0 0.2 0.07 0.04 
 DMI (% of BW) 1.82 1.79 0.03 0.44 0.10 
 EBAL (Mcal/d) 5.4 4.4 0.4 0.05 0.11 
 Rumination (min/d) 521 500 7 0.03 0.77 
 BW (kg) 808 790 4 <0.001 0.02 
 BW change1 (kg) 17 6 4 0.04 ― 
 BCS 3.37 3.29 0.02 0.008 0.32 
Postpartum      
 DMI (kg/d) 21.7 22.2 0.4 0.51 0.16 
 DMI (% of BW) 3.09 3.16 0.06 0.36 0.20 
 EBAL (Mcal/d) -11.8 -11.9 0.7 0.91 0.66 
 Rumination (min/d) 512 523 11 0.61 0.34 
 BW (kg) 713 708 5 0.42 0.82 
 BW change1 (kg) -36 -36 7 0.96 ― 
 BCS 3.14 3.11 0.03 0.34 0.01 
 Colostrum weight (kg) 7.3 5.8 0.7 0.16 ― 
 Colostrum IgG (mg/dL) 7628 8342 469 0.29 ― 
 Colostrum IgG yield (g) 494 441 40 0.35 ― 
 Milk yield (kg/d) 48.0 47.5 0.7 0.58 0.99 
 Fat (%) 4.17 4.32 0.08 0.17 0.05 
 Fat (kg/d) 1.98 2.03 0.04 0.35 0.26 
 3.5% FCM2 (kg/d) 52.9 53.6 0.9 0.59 0.45 
 Protein (%) 3.19 3.30 0.05 0.09 0.24 
 Protein (kg/d) 1.51 1.55 0.03 0.33 0.88 
 Lactose (%) 4.58 4.59 0.02 0.78 0.59 
 Lactose (kg/d) 2.22 2.20 0.04 0.67 0.54 
 TS (%) 13.03 13.32 0.11 0.07 0.18 
 TS (kg/d) 6.23 6.30 0.10 0.65 0.66 
 ECM3 (kg/d) 53.0 53.8 0.9 0.50 0.57 
 ECM/DMI 2.47 2.47 0.05 0.95 0.47 
 MUN (mg/dL) 12.46 10.90 0.43 0.01 0.87 
 SCS 1.07 1.08 0.25 0.98 0.72 
1 Change in BW from wk -3 to -1 (prepartum) and wk 1 to 4 (postpartum), relative to calving 
2 3.5% FCM = (0.432 × kg of weekly average milk yield) + (16.216 × kg of fat). 
3 ECM = (0.327 × kg of weekly average milk yield) + (12.95 × kg of fat) + (7.65 × kg of true protein). 
 
For the reproductive analysis, 11 out of 52 animals (CON = 8 cows, EXP = 3 cows) 
were right censored due to being culled before becoming pregnant (n = 1) or not 
becoming pregnant during the first 150 DIM (n = 10).The median time to pregnancy during 
the first 150 days postpartum for animals fed the EXP diet was 70 DIM while the CON-
fed cows had a median time of 89 DIM (Figure 3A). Treatment [hazard ratio (95% CI) for 
EXP vs. CON = 1.76 (0.93 – 3.33); P = 0.08] tended to be associated with time to 
pregnancy such that EXP-fed cows had a higher hazard of becoming pregnant by 150 
DIM. 
 
In relation to Ca status, 0/12 eucalcemic cows, 5/30 SCH cows, and 6/10 cSCH 
cows were right censored. The median time to pregnancy during the first 150 days for 
eucalcemic cows was 69 DIM compared to 73 DIM for cows categorized as having SCH. 
Only 40% of cows with cSCH became pregnant by 150 DIM (Figure 3B). Calcium status 
was found to be associated with time to pregnancy (P = 0.01). Compared to eucalcemic 
cows cSCH cows had a significantly lower hazard [0.18 (95% CI = 0.06 – 0.57); P < 0.01] 
of becoming pregnant within 150 DIM while cows with SCH did not differ from eucalcemic 
cows (P = 0.29).  
 
 
Figure 3. A) Survival curves estimating the time to pregnancy by treatment group B) 
Survival curves estimating the time to pregnancy for cows categorized as being 
eucalcemic (no SCH; 0 samples with Ca < 2.12 mmol/L), subclinical 
hypocalcemic (SCH; 1 to 3 samples with Ca < 2.12 mmol/L), or chronic 
subclinical hypocalcemic (cSCH; all 4 samples with Ca < 2.12 mmol/L) between 
calving and 3 DIM. 
 
To our knowledge, this is the first study evaluating the effect of synthetic zeolite A 
on reproductive measures. Evaluating reproductive performance was not a primary 
objective of this study and the study was not powered to evaluate differences between 
treatments. These results should be interpreted as preliminary findings in need of further 
research involving more cows to validate the improved time to pregnancy findings of this 
study.  
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CONCLUSIONS AND IMPLICATIONS 
 
 Supplementing cows with synthetic zeolite A for three weeks before parturition 
improved Ca status during the periparturient period however, postpartum performance 
was similar between the two treatment groups. Numerically, cows fed zeolite A had 
improved time to pregnancy, though further work needs to be done to validate these 
findings. We also did not observe a treatment effect on oxidative metabolism as reflected 
in the lack of change of OSi.   
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